Hyphens Pharma Officially Launches Singapore’s First HSA-Approved Online Pharmacy

Specialty pharma and consumer healthcare company Hyphens Pharma has officially launched the first digital pharmacy approved by the Health Sciences Authority of Singapore.


Hyphens Pharma is active in three business sectors: specialty pharmacy, proprietary brands and medical hypermarket and digital. It has established its presence in major Southeast Asian countries including Singapore, Vietnam, Malaysia, Indonesia and the Philippines. The group also manages a marketing and distribution network covering 10 other markets in Asia-Pacific.

Its latest business, WellAway, operated by its digital business DocMed, enables patients to receive electronic prescriptions from qualified physicians and have their prescription drugs delivered directly to them.

Since obtaining a business license in January last year, the online pharmacy has registered with more than 100 clinics in the island city-state. Hyphens Pharma aims to onboard approximately 1,000 additional clinics to the platform by the end of the year, a noted report.

WellAway is currently offering limited-time free delivery of pharmaceuticals for doctors on its platform.


Based on a press release, WellAway services are useful for elderly, immobile, self-isolating patients and those who simply prefer to reduce outside contact during the ongoing pandemic.

An HSA-registered online pharmacy is expected to send traceable digital scripts directly from clinics and protect patient data by implementing cybersecurity measures. Qualified pharmacists must also manage pharmacy operations, including the storage and supply of registered therapeutic products. In addition to this, WellAway has also added specialized handling for temperature-sensitive medications.

At the same time, Hyphens Pharma is collaborating with the pharmaceutical group Servier Singapore to further develop its new online pharmacy service.


Some acquisitions have been made in the digital pharmacy scene in Asia-Pacific over the past few months. For one, Indian e-commerce platform Flipkart has signed deals to buy a majority stake in the online pharmacy startup Sasta Sundar. Digital pharmacy PharmEasy, meanwhile, acquired Aknamed, a cloud-based healthcare supply chain platform, as part of its drive to diversify its healthcare business. In New Zealand, the Green Cross Health hospital group has taken a quarter of the capital of the digital pharmacy PillDrop.


“I believe digitalization is the future of the pharmaceutical industry and working with WellAway certainly enables us to better meet the needs of our patients in the new digital age,” commented Florent De Kertanguy, Managing Director of Servier Singapore.

Leave a Reply

Your email address will not be published. Required fields are marked *